- Home
- ACCD vs HRTX Comparison
ACCD vs HRTX Comparison
Compare ACCD & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACCD
- HRTX
- Stock Information
- Founded
- ACCD 2007
- HRTX 1983
- Country
- ACCD United States
- HRTX United States
- Employees
- ACCD N/A
- HRTX N/A
- Industry
- ACCD Business Services
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- ACCD Consumer Discretionary
- HRTX Health Care
- Exchange
- ACCD Nasdaq
- HRTX Nasdaq
- Market Cap
- ACCD 281.1M
- HRTX 240.3M
- IPO Year
- ACCD 2020
- HRTX 1987
- Fundamental
- Price
- ACCD $3.40
- HRTX $1.58
- Analyst Decision
- ACCD Buy
- HRTX Strong Buy
- Analyst Count
- ACCD 12
- HRTX 3
- Target Price
- ACCD $8.96
- HRTX $5.67
- AVG Volume (30 Days)
- ACCD 1.0M
- HRTX 6.1M
- Earning Date
- ACCD 01-09-2025
- HRTX 11-12-2024
- Dividend Yield
- ACCD N/A
- HRTX N/A
- EPS Growth
- ACCD N/A
- HRTX N/A
- EPS
- ACCD N/A
- HRTX N/A
- Revenue
- ACCD $441,028,000.00
- HRTX $137,737,000.00
- Revenue This Year
- ACCD $14.58
- HRTX $13.10
- Revenue Next Year
- ACCD $12.65
- HRTX $18.76
- P/E Ratio
- ACCD N/A
- HRTX N/A
- Revenue Growth
- ACCD 16.04
- HRTX 12.13
- 52 Week Low
- ACCD $3.08
- HRTX $1.04
- 52 Week High
- ACCD $15.36
- HRTX $3.93
- Technical
- Relative Strength Index (RSI)
- ACCD 43.87
- HRTX 52.12
- Support Level
- ACCD $3.41
- HRTX $1.46
- Resistance Level
- ACCD $3.61
- HRTX $1.88
- Average True Range (ATR)
- ACCD 0.17
- HRTX 0.14
- MACD
- ACCD -0.02
- HRTX 0.01
- Stochastic Oscillator
- ACCD 37.10
- HRTX 28.57
About ACCD Accolade Inc.
Accolade Inc offers technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. The company's platform combines open, cloud-based intelligent technology with multimodal support from a team of Accolade Care Advocates and clinicians, including registered nurses, physician medical directors, pharmacists, primary care physicians, and other professionals to provide advocacy, medical opinion, and virtual primary care services.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.